NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) Stock Analysis - Hedge Fund Holdings

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a publicly traded Healthcare sector company. As of May 20, 2026, NAMS trades at $35.77 with a market cap of $3.99B and a P/E ratio of -20.07. NAMS moved +6.11% today. Year to date, NAMS is +6.78%; over the trailing twelve months it is +84.75%. Its 52-week range spans $14.06 to $42.21. Analyst consensus is strong buy with an average price target of $48.00. Rallies surfaces NAMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NAMS stock?

Hedge funds tracked by Rallies that own NAMS include Viking Global, Duquesne Family, Maverick Capital, Centerbook Partners, and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NewAmsterdam Pharma Company N.V. Ordinary Shares.

NAMS Key Metrics

Key financial metrics for NAMS
MetricValue
Price$35.77
Market Cap$3.99B
P/E Ratio-20.07
EPS$-1.79
Dividend Yield0.00%
52-Week High$42.21
52-Week Low$14.06
Volume1.15M
Avg Volume0
Revenue (TTM)$22.57M
Net Income$-212.73M
Gross Margin0.00%

Top Hedge Funds Holding NAMS

  • Viking Global holds 4.20M shares of NAMS, changed +0.00% as of Mar 31, 2026.
  • Duquesne Family holds 3.07M shares of NAMS, changed +0.00% as of Mar 31, 2026.
  • Maverick Capital holds 2.19M shares of NAMS, changed +15.42% as of Mar 31, 2026.
  • Centerbook Partners holds 22.25K shares of NAMS, changed +84.53% as of Mar 31, 2026.
  • Polen Capital holds 11.24K shares of NAMS, changed +0.00% as of Dec 31, 2025.

Latest NAMS News

Recent NAMS Insider Trades

  • LANGE LOUIS G sold 44.17K (~$1.34M) on Mar 11, 2026.
  • LANGE LOUIS G sold 446 (~$13.93K) on Mar 11, 2026.
  • Kastelein Johannes Jacob Pieter sold 101.41K (~$3.07M) on Mar 9, 2026.

NAMS Analyst Consensus

11 analysts cover NAMS: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.00.

Common questions about NAMS

Who owns NAMS stock?
Hedge funds tracked by Rallies that own NAMS include Viking Global, Duquesne Family, Maverick Capital, Centerbook Partners, and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NewAmsterdam Pharma Company N.V. Ordinary Shares.
Does Rallies show 13F holders for NAMS?
Yes. Rallies tracks hedge fund and 13F ownership data for NAMS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NAMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NAMS. It does not provide personalized investment advice.
NAMS

NAMS